ArticleJournal of drug assessment2020

Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer.

Lakyn Husinka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.